Findings from the Canadian Registry for Amyloidosis Research: Neurological Manifestations (P12-11.011)
The objective of the Canadian Registry for Amyloidosis Research (CRAR) is to improve the understanding of the Canadian amyloidosis landscape in order to improve patient care. In this study, we report neuropathy data from an initial cohort of Canadians with amyloidosis.
Authors
- Christopher P. Venner (ORCID: https://orcid.org/0000-0003-4701-4285)
- Nowell Mark Fine (ORCID: https://orcid.org/0000-0002-6546-6587)
- Steven K. Baker (ORCID: https://orcid.org/0000-0002-8586-8786)
- Donna Reece (ORCID: https://orcid.org/0009-0002-9686-4323)
- Margot K. Davis (ORCID: https://orcid.org/0000-0001-7367-8267)
- Victoria Hodgkinson (ORCID: https://orcid.org/0000-0001-5908-2694)
- Rami Massie (ORCID: https://orcid.org/0000-0001-8219-1020)
- Vera Bril (ORCID: https://orcid.org/0000-0002-5805-4883)
- Diego Delgado (ORCID: https://orcid.org/0000-0001-6587-3484)
Institutions
- University of British Columbia (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- McGill University (CA)
- McMaster University (CA)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210415
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00